A PHARMACEUTICAL COMPOSITION OF FXR AGONIST AND ITS PREPARATION METHOD Application WO-2023035181-A1 World Intellectual Property Organisation (WIPO) 16 Mar 2023
Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy Grant US-11400072-B2 United States of America 02 Aug 2022
PPARy agonist for treatment of progressive supranuclear palsy Grant US-11253508-B2 United States of America 22 Feb 2022
AZETIDINE DERIVATIVES AS FXR (NR1H4) MODULATORS Application EP-3730487-A1 European Patent Office 28 Oct 2020
COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD) Application WO-2020205024-A1 World Intellectual Property Organisation (WIPO) 08 Oct 2020
METHODS OF PROMOTING HEPATIC REGENERATION Application EP-3352768-A4 European Patent Office 24 Apr 2019
FXR (NR1H4) MODULATING COMPOUNDS Application WO-2017218337-A1 World Intellectual Property Organisation (WIPO) 21 Dec 2017